medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2003, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2003; 2 (2)


Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha

Góra-Gbka M, Liberek A, Szydowska-ysiak W, Bako W, Korzon M

Idioma: Ingles.
Referencias bibliográficas: 54
Paginas: 92-97
Archivo PDF: 66.05 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364-375.

  2. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J. Tumor Necrosis Factor a and Interleukin 6 plasma Levels in Infected Cirrhotic Patients. Gastroenterol 1993; 104: 1492-1497.

  3. Czerwionka-Szaflarska M, Pawlowska M, Halota W. Interleukin (Il-1 beta, Il-2, Il-4 and Il-6) concentrations in patients with chronic B and C hepatitis. Materialy Naukowe Konferencji Polskiego Towarzystwa Hepatologicznego maj 1996; 67.

  4. Gregorio GV, Hussain M, Mieli-Vergani G, Vergani D. Elevated Il-6 levels presage and accompany anti-HBe seroconversion during interferon treatment of chronic hepatitis B virus infection. J Hepatol 1996; 26 (suppl): 83.

  5. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ito Y, Takayanagi M, Ida N. Serum interleukin 6 levels in patients with chronic hepatitis B. Am J Gastroenterol 1991: 86: 1804-1808.

  6. Pawlowska M, Czerwionka-Szaflarska M, Halota W. Cytokin (Il-1 beta, Il-2, Il-4 and Il-6) concentration in patients with chronic hepatitis during the treatment with interferon-alpha. Materialy Naukowe Konferencji Polskiego Towarzystwa Hepatologicznego 30 maj 1996; 68.

  7. Socha P, Janas R, Socha J, Pawlowska J, Wozniak M, Woynarowski M. Czy TNF-a i Il-6 moga byc pomocne w ocenie przewleklego zapalenia watroby u dzieci? Wiad Lek 1994; 47: 493-496.

  8. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterol 1992; 103:264-274.

  9. Torre D, Zeroli C, Giola M, Ferrario G, Fiori GP, Bonetta G, Tambini R. Serum levels of interleukin-1 alpha, interleukin-beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994; 18 (2): 194-198.

  10. Kakumu S, Fukatsu A, Shinagawa T, Kurokawa S, Kusakabe A. Localization of intrahepatic interleukin 6 in patients with acute and chronic liver disease. J Clin Pathol 1992; 45: 408-411.

  11. Ohno H, Kaneko S, Kobayashi K, Murakami S. Human Hepatitis B Virus Enhancer 1 is Responsive to Human Interleukin-6. J Med Virol 1997; 52: 413-418.

  12. Schmitt E, Hoehn P, Huels C. T helper type 1 development of naive CD4+ t cells requires the coordinate action of interleukin 12 and interferon gamma and is inhibited by transforming growth factor-beta. Eur J Immunol 1994; 24: 793-798.

  13. Vingerhoets J, Michielsen P, Vanham G, Bosmans E, Paulij W, RamonA, Palcmans P, et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998; 28: 8-16.

  14. Lee Y, Park US, Choi I, Yoon SK, Park YM, Lee YI. Human Interleukin 6 Gene Is Activated by Hepatitis B Virus-X Protein in Human Hepatoma Cells. Clin Cancer Res 1998; 4: 1711-1717.

  15. Müller C, Zielinski C. Interleukin 6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis. J Hepatol 1992; 15: 372-377.

  16. Nobuo I, Shingou S, Touko H, Kazuo H, Tetsunosuke K, Yoshiharu M, Masayoshi K. An enzyme-linked immunosorbent assay for measurement of human interleukin-6. J Immunol Methods 1990; 133: 279-284.

  17. Rossol S, Marinos G, Carruci P, Singer MV, Williams R, Naoumov N. Interleukin-12 Induction of Th1 Cytokines is Important for Viral Clearance in Chronic Hepatitis B. J Clin Invest 1997; 99: 3025-3033.

  18. Gabriel A, Ziólkowski A. Zasady numerycznej oceny biopsji watroby. Propozycja protokolu badania histopatologicznego bioptatu wartroby w diagnostyce przewleklych zapalen. Hepatol Pol 1997; 4(suppl1): 33-39

  19. Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis. J Viral Hepat 1996; 3: 277-283.

  20. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ida N. Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jap 1993; 28: 18-24.

  21. Cielecka B. Aktualne problemy rozpoznawania i leczenia chorób watroby wywolanych zakazeniem wirusem HBV u dzieci. Przegl Ped 1993; 23: 627-633.

  22. Woynarowski M, Pawlowska J, Socha J. Przewlekle zapalenie watroby u dzieci. Medipress Pediatria 1995; 4: 8-13.

  23. Woynarowski M. Specifity of viral liver disease in children. Hepatol Pol 1997; 4: 73-76.

  24. Alexander G. Historia naturalna i leczenie wirusowego zapalenia watroby typu B. Zeszyty hepatologiczne 1992; 5: 15-19.

  25. Bortolotti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M, Noventa F, Calzia R, et al. G. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990; 99: 805-810.

  26. Bruguera M, Amat L, Garcia O, Lambruschini N, Carnicer J, Bergada A, Martin-Orte E, et al. Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection. J Clin Gastroenterol 1993; 17: 296-299.

  27. Karasinska M. Aspekty epidemiologiczne i nastepstwa przewleklego zakazenia wirusem Hepatitis B (WHB) u dzieci. Wiad Lek 1991; 44: 26-29.

  28. Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H. Elevated serum Il-6 levels in patients with acute hepatitis. J Clin Immunol 1992; 12: 197-200.

  29. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R. Regulation of human cytolitic lymphocyte responces by interleukin 12. Cell 1992; 143: 127-142.

  30. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17-23.

  31. Lee WM. Hepatitis B Virus Infection. N Engl J Med 1997; 337: 1743-1745.

  32. Louis-Jacques O, Olson AD. Cost-Benefit Analysis of Interferon Therapy in Children with Chronic Active Hepatitis B. J Pediatr Gastroenterol Nutr 1997; 24: 25-32.

  33. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335-1340.

  34. Mondelli MU. Role of the immune system in liver damage. Hepatol Pol 1997; 4: 89-90.

  35. Guida S, Fiore M, Scotese I, Iorio R, Gaentaniello L, Vegnente A, Pignata C. Defective interleuki-2 production in children with chronic hepatitis B: role of adherent cells. J Pediatr Gastroenterol Nutr 1997; 24: 312-316.

  36. Waage A, Kaufman C, Espevik T. Interleukin 6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989; 5: 394-400.

  37. Gerok W, Decker K, Andus T, Gross V. Cytokines and the Liver. Falk Symposium 78. Kluwer Academic Publishers 1995; 14-31, 58-83.

  38. Al.-Wabel A, Al.-Janadi M, Raziuddin S. Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol 1993; 92: 902-908.

  39. Gladysz A, Simon K, Woynarowski M. Wyniki leczenia interferonami przewleklych wirusowych zapalen watroby u doroslych i dzieci–badanie ogólnopolskie. Hepatol Pol 1997; 4 (supll. 1): 48-52.

  40. Torre D, Tambini R. Interferon-a therapy for chronic hepatitis B in children: a meta-analysis. Clin Infect Dis 1996; 23: 131-137.

  41. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.

  42. Jonas MM. Interferon–a for viral hepatitis. J Pediatr Gastroenterol Nutr 1996; 23: 93-106.

  43. Juszczyk J. Mechanizmy smierci komórki watrobowej. Zeszyty hepatologiczne1998; 9: 19-24.

  44. Mantovani A. The Interplay between Primary and Secondary Cytokines. Cytokines Involved in the Regulation of Monocyte Recruitment. Drugs 1997; 54 (suppl): 15-23.

  45. Bertagnolli MM, Lin BY, Young D, Herrmann SH. Il-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol 1992; 149: 3778-3783.

  46. D‘Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, et al. Production of natural killer cell stimulatory factor (Interleukin-12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387-1393.

  47. Kiniva M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin–4 stimulated lymphocytes. J Clin Invest 1992: 262-266.

  48. Kobayashi M, Fitz L, Ryan M. Identification and purification of Natular Killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-846.

  49. Kubin M. Interleukina-12–nowa cytokina o potencjalnym znaczeniu klinicznym. Klinika 1995; 3: 14-17.

  50. Manetti R, Parronchi P, Giudizi MG. Natural killer cell stimulatory factor interleukin 12 (Il-12) induces T helper type 1 (Th1) – specific immune responses and inhibits the development of Il-4 producing Th cells. J Exp Med 1993; 177: 1199-2004.

  51. Trinchieri G. Interleukin 12: a proinflamatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu Rev Immunol 1995; 1995: 13: 251-276.

  52. Wenner CA, Guler ML, Macatonia SE, O‘Garra A, Murphy KM. Roles if INF-gamma and INF-alpha in Il-12-induced T helper cell-1 development. J Immunol 1996; 156: 1442-1447.

  53. Schlaak JF, Tully G, Löhr HF, Gerken G, Meyer zum Büschenfelde. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pr- and anti-inflammatory cytokines. Clin Exp Immunol 1999; 115: 508-514.

  54. Wolf SF, Sieburth D, Sypek J. Interleukin-12: a key modulator of immune function. Stem Cells 1994; 12: 154-168.




2020     |     www.medigraphic.com